Ontario Teachers Pension Plan Board grew its stake in DaVita Inc. (NYSE:DVA – Free Report) by 73.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,341 shares of the company’s stock after purchasing an additional 9,874 shares during the quarter. Ontario Teachers Pension Plan Board’s holdings in DaVita were worth $3,325,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of DVA. National Pension Service boosted its holdings in DaVita by 74.3% in the 1st quarter. National Pension Service now owns 197 shares of the company’s stock worth $30,000 after buying an additional 84 shares during the last quarter. Hantz Financial Services Inc. lifted its position in shares of DaVita by 48.1% in the second quarter. Hantz Financial Services Inc. now owns 231 shares of the company’s stock valued at $33,000 after acquiring an additional 75 shares in the last quarter. Y.D. More Investments Ltd acquired a new stake in shares of DaVita in the first quarter worth approximately $35,000. Mid American Wealth Advisory Group Inc. purchased a new stake in shares of DaVita during the second quarter worth approximately $36,000. Finally, Ameritas Advisory Services LLC acquired a new position in DaVita in the 2nd quarter valued at $47,000. 90.12% of the stock is owned by hedge funds and other institutional investors.
DaVita Price Performance
Shares of NYSE DVA opened at $121.55 on Friday. The company has a market capitalization of $8.58 billion, a P/E ratio of 12.52, a P/E/G ratio of 0.91 and a beta of 1.13. The company has a 50 day simple moving average of $127.68 and a 200-day simple moving average of $135.37. DaVita Inc. has a 1 year low of $115.39 and a 1 year high of $179.60.
Wall Street Analyst Weigh In
Several brokerages have issued reports on DVA. Truist Financial set a $140.00 target price on shares of DaVita in a research note on Tuesday, October 14th. Weiss Ratings restated a “hold (c)” rating on shares of DaVita in a research report on Thursday. Zacks Research downgraded shares of DaVita from a “hold” rating to a “strong sell” rating in a report on Thursday, October 30th. Barclays lowered their target price on DaVita from $149.00 to $143.00 and set an “equal weight” rating on the stock in a report on Thursday, October 30th. Finally, Wall Street Zen lowered DaVita from a “buy” rating to a “hold” rating in a research report on Saturday, October 11th. Five analysts have rated the stock with a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus price target of $148.00.
Read Our Latest Research Report on DVA
DaVita Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Stories
- Five stocks we like better than DaVita
- The Significance of Brokerage Rankings in Stock Selection
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.
